Health Care Equipment

SISRAM MED

Intel

Conference Minutes

00981

SFTBY

9984

SOBKY

MBLY

NVDA

ASIC

LAKE

SOXS

SOXL

SOXX

CP00062

INTC

01696

NVMI

NOVAQ

NOVA

HSMD

688981

CCGWW

04335

<p>The following are the minutes of the Q3 2025 earnings call for <span class="security-tag" type="security-tag" counter_id="ST/US/INTC" name="Intel" trend="">$Intel(INTC.US)</span> compiled by Dolphin Research. For an interpretation of the earnings report, please refer to &#34;Intel: Stopping Losses and Recovering! Can the 'American SMIC' Poach TSMC?&#34; 1. Core Financial Data of Intel's Earnings Report Q3 Financial Data: Revenue: $13.7 billion, exceeding the upper limit of the expected range, with a quarter-on-quarter growth of 6%. Gross Margin: (Non-GAAP) Gross margin was 40%, 4 percentage points higher than the performance guidance. This performance was attributed to revenue growth, improved product mix, and reduced inventory write-downs...</p>

SMIC

Taiwan Semiconductor

SoftBank

SoftBank Group Corp.

Cheche

Mobileye Global

NVIDIA

Ategrity Specialty Holdings LLC

Lakeland Industries

Direxion Semicon Bear 3X

Direxion Semicon Bull 3X

iShares Semiconductor ETF

Semiconductor

Nova

SUNNOVA ENERGY INTERNATIONAL INC

Sunnova Energy

SMIC HK SDR 5to1

Cheche Group - CW28

INTEL-T

Intel (Minutes): 18A is expected to contribute to profits by the end of 2026

SISRAM MED released FY2025 Q1 earnings on August 20 (BJT), actual revenue HKD 643.65 M, actual EPS HKD 0.0532

ReAve Medical Technology's Revenue Down 1.9% in H1 2025 Earnings Report

SISRAM MED released FY2025 Q2 earnings on August 20 After-Market (BJT), actual revenue HKD 649.49 M, actual EPS HKD 0.0537

SISRAM MED released FY2025 Semi-Annual earnings on August 20 After-Market (BJT), actual revenue HKD 1.293 B, actual EPS HKD 0.107

SISRAM MED to Release FY2025 Semi-Annual Earnings on August 20, 2025 (BJT)

Revalo Medical Technology Launches AI-based Skincare Product

Revaldo Medical Technology Strengthens Market Penetration in Asia-Pacific and North America

SISRAM MED released FY2024 9 Months Earnings on March 19 (BJT), with actual revenue of 2.02 B HKD and EPS of 0.3001 HKD

SISRAM MED released FY2024 Q3 earnings on March 19 (BJT), actual revenue 700.9 M HKD, actual EPS 0.1173 HKD

Furu Medical Technology Announces 2024 Annual Results, Revenue of $349 Million, Down 2.83% Year-on-Year

Furuya Medical Technology Announces Final Dividend of HKD 0.126 per Share for Fiscal Year 2024

SISRAM MED released FY2024 Q4 earnings on March 19 After-Market (BJT), actual revenue 700.37 M HKD, actual EPS 0.1172 HKD

SISRAM MED released FY2024 annual earnings on March 19 After-Market (BJT), actual revenue 2.721 B HKD (forecast 2.964 B HKD), actual EPS 0.4177 HKD (forecast 0.4668 HKD)

SISRAM MED to Release FY2024 Earnings on March 19 After-Market (BJT), Forecast Revenue 2.957 B HKD, EPS 0.4668 HKD

Furuya Medical Technology Obtains EU Medical Device Regulation Certification

Furu Medical Technology Launches New Version of Alma Harmony Beauty Platform

Guohai Securities Releases Research Report on Medical Beauty Industry

Revance Therapeutics' DaxibotulinumtoxinA-lanm Approved

Furuya Medical Technology Grants Restricted Share Units

Fosun Pharma Releases 2024 Interim Results

CMON

CHINAENERGY RTS

CHINA NEW HLDGS

CHI KINGSTONE

BHCC HOLDING

ST HLDGS

SHEUNG YUE GP

CENTURY GINWA

ADTIGER CORP

SHUOAO INTL

ANGELALIGN

ZYLOXTB

AK MEDICAL

CHUNLI MEDICAL

SCIENTECH

MODERN DENTAL

ACOTEC-B

PW MEDTECH

HEARTCARE-B

GAUSH MEDITECH

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio